For the best experience of the website, please view this site in either Microsoft Edge, Google Chrome, Safari internet browsers rather than Internet Explorer.    
Research breakthrough

Baricitinib delays the progression of type 1 diabetes

In a world-first, ATIC researchers lead by Professor’s Thomas Kay and Helen Thomas have shown that baricitinib, an immunotherapy treatment commonly used in rheumatoid arthritis, can delay the progression of type 1 diabetes and preserve the body’s ability to make its own insulin.

Learn more
Our domains

What does ATIC do?

ATIC is working across six distinct interconnected Domains to ensure maximum impact and fulfil our bold vision.
Current trials

T1D RELAY - Rituximab-pvvr and Abatacept Newly Diagnosed Study

ATIC is conducting the TrialNet lead T1D RELAY trial in Melbourne at The Royal Melbourne Hospital. T1D RELAY is available for people ages 8-45 years who have been diagnosed with type 1 diabetes in the last three months.

Learn More
News & Events

Events

Clinical translation of antigen-specific immunotherapy for type 1 diabetes – from discovery to clinical trials

June 2024

Seminar 17, Beyond Insulin Seminar Series – Professor Ranjeny Thomas talk about ‘clinical translation of antigen-specific immunotherapy for type 1 diabetes’.


Events

Measuring what matters: psychosocial and behavioural outcomes in T1D trials

May 2024

Seminar 16, Beyond Insulin Seminar Series – Dr Elizabeth Holmes-Truscott present ‘Measuring what matters: the assessment of psychosocial and behavioural outcomes in type 1 diabetes trials’.


Events

PANDA (Pan autoantibody negative diabetes in adults) study

April 2024

Seminar 15, Beyond Insulin Seminar Series – Dr Shivani Patel from the Garvan Institute of Medical Research will present ‘PANDA (Pan autoantibody negative diabetes in adults) study’.


Events

Lessons from a failed coeliac disease trial: a new way forwards?

March 2024

Seminar 14, Beyond Insulin Seminar Series – Associate Professor Jason Tye-Din from WEHI will present ‘Lessons from a failed coeliac disease trial: a new way forwards?’


Partnerships

We partner with global leaders in our field

Supported by
Coordinating Centre